financetom
Business
financetom
/
Business
/
Vertex Pharmaceuticals Signs Reimbursement Deal With Italy for Casgevy Therapy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vertex Pharmaceuticals Signs Reimbursement Deal With Italy for Casgevy Therapy
Sep 18, 2025 8:26 AM

09:29 AM EDT, 09/18/2025 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) said Thursday it has signed a reimbursement deal with the Italian Medicines Agency for eligible patients to access Casgevy, a gene-edited therapy to treat transfusion-dependent beta thalassemia and severe sickle cell disease.

Financial terms were not disclosed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved